DE3571615D1 - Process for epimerization at c6 of 3,4,5,6-tetra-hydro-2h-pyran-2-one - Google Patents

Process for epimerization at c6 of 3,4,5,6-tetra-hydro-2h-pyran-2-one

Info

Publication number
DE3571615D1
DE3571615D1 DE8585107018T DE3571615T DE3571615D1 DE 3571615 D1 DE3571615 D1 DE 3571615D1 DE 8585107018 T DE8585107018 T DE 8585107018T DE 3571615 T DE3571615 T DE 3571615T DE 3571615 D1 DE3571615 D1 DE 3571615D1
Authority
DE
Germany
Prior art keywords
epimerization
pyran
hydro
tetra
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8585107018T
Other languages
English (en)
Inventor
Gerald E Stokker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Application granted granted Critical
Publication of DE3571615D1 publication Critical patent/DE3571615D1/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30—Oxygen atoms, e.g. delta-lactones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic System
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
DE8585107018T 1984-06-11 1985-06-07 Process for epimerization at c6 of 3,4,5,6-tetra-hydro-2h-pyran-2-one Expired DE3571615D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/619,506 US4588820A (en) 1984-06-11 1984-06-11 Process for epimerization at C6 of 3,4,5,6-tetrahydro-2H-pyran-2-one

Publications (1)

Publication Number Publication Date
DE3571615D1 true DE3571615D1 (en) 1989-08-24

Family

ID=24482190

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8585107018T Expired DE3571615D1 (en) 1984-06-11 1985-06-07 Process for epimerization at c6 of 3,4,5,6-tetra-hydro-2h-pyran-2-one

Country Status (5)

Country Link
US (1) US4588820A (de)
EP (1) EP0164698B1 (de)
JP (1) JPS611681A (de)
CA (1) CA1228591A (de)
DE (1) DE3571615D1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4904646A (en) * 1987-05-22 1990-02-27 E. R. Squibb & Sons, Inc. Phosphorus-containing HMG-COA reductase inhibitors
US5091378A (en) * 1987-05-22 1992-02-25 E. R. Squibb & Sons, Inc. Phosphorus-containing HMG-CoA reductase inhibitors, new intermediates and method
US4820850A (en) * 1987-07-10 1989-04-11 Merck & Co., Inc. Process for α-C-alkylation of the 8-acyl group on mevinolin and analogs thereof
US5506219A (en) * 1988-08-29 1996-04-09 E. R. Squibb & Sons, Inc. Pyridine anchors for HMG-CoA reductase inhibitors
US20010006644A1 (en) 1997-07-31 2001-07-05 David J. Bova Combinations of hmg-coa reductase inhibitors and nicotinic acid and methods for treating hyperlipidemia once a day at night
KR100407758B1 (ko) 2001-08-27 2003-12-01 씨제이 주식회사 스타틴의 제조에 있어서 락톤화 방법
TWI332953B (en) 2002-02-08 2010-11-11 Mitsubishi Rayon Co Method for preparing lactone
US7889176B2 (en) 2006-07-18 2011-02-15 Avago Technologies General Ip (Singapore) Pte. Ltd. Capacitive sensing in displacement type pointing devices
KR100836960B1 (ko) 2007-09-07 2008-06-10 주식회사 서울제약 새로운 나이아신 제어방출형 제제

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53147073A (en) * 1977-05-24 1978-12-21 Sankyo Co Ltd Mevalonolactone derivatives
IL60751A (en) * 1979-08-17 1985-04-30 Merck & Co Inc 6-(2'-((substituted phenyl)ethyl and-ethenyl)-4-hydroxy-tetrahydro-2h-pyran-2-one derivatives,their preparation and pharmaceutical compositions containing them
US4444784A (en) * 1980-08-05 1984-04-24 Merck & Co., Inc. Antihypercholesterolemic compounds
EP0068038B1 (de) * 1981-06-29 1985-09-25 Merck & Co. Inc. (+)-(4R.6S)-(E)-6-(2-(4'-Fluor-3,3',5-trimethyl-(1,1'-biphenyl)-2-yl)ethenyl)-3,4,5,6-tetrahydro-4-hydroxy-2H-pyran-2-on, Verfahren zu seiner Herstellung und eine diese Verbindung enthaltende pharmazeutische Zusammensetzung

Also Published As

Publication number Publication date
JPS611681A (ja) 1986-01-07
EP0164698A2 (de) 1985-12-18
US4588820A (en) 1986-05-13
EP0164698A3 (en) 1986-11-20
EP0164698B1 (de) 1989-07-19
CA1228591A (en) 1987-10-27

Similar Documents

Publication Publication Date Title
PL256983A1 (en) Method of obtaining novel derivatives of cyclohexanodione-1,3
EP0302020A3 (en) Process for the preparation of 2,2,6,6-tetramethyl-4-piperidyl-amines
PL256985A1 (en) Method of obtaining novel derivatives of cyclohexanodione-1,3
HU900191D0 (en) Process for preparation of 1,1,1-trifluor-2-aryl-propane-3-ols
DE3662256D1 (en) Process for the preparation of (2,2)-paracyclophane
PL256984A1 (en) Method of obtaining novel derivatives of cyclohexanodione-1,3
SG94591G (en) Process for preparation of (2,2)-paracyclophane
DE3569375D1 (en) Process for the preparation of 1,2-benzisothiazolones
IL82858A0 (en) Process for the preparation of 1,2,5,6,9,10-hexabromo-cyclododecane
DE3571615D1 (en) Process for epimerization at c6 of 3,4,5,6-tetra-hydro-2h-pyran-2-one
DE3561054D1 (en) Process for the preparation of 2,4-dichloro-5-fluoro-benzoic acid
IL86646A (en) Process for the preparation of 5,11-di-and 5,6,11,12-tetraphenylnaphthacenes
DE3568327D1 (en) Process for the preparation of 2,3,5-trimethylbenzoquinone
YU167087A (en) Process for obtaining 4,4-dialkyl-2-azetidinone
PT83884A (en) Process for the preparation of 1 azolyl-3,3-dimethyl-tutan-2-on-and-ol derivatives
EP0179654A3 (en) Process for the preparation of 5,6,7,8-tetrahydrofolic acid
PT83799A (en) Process for the preparation of novel 2,2:-bi-1h-imidazoles
HUT37591A (en) Process for preparing /1,3-dioxi-1,3-propane-diil/-diimino/ -bis-benzoic acid and its derivatives
EP0198795A3 (en) Process for the preparation of 1,4-diaminoanthraquinones
EP0297239A3 (en) Process for the preparation of hexadiin(2,4)-diol-1,6
GB2165242B (en) Process for the preparation of 1, 2-benzoxathiine derivatives
PT81633A (en) Process for the preparation of 1,4-dihydropiridine derivatives
EP0186629A3 (en) Process for the preparation of 3,5-dialkyl-4-hydroxybenzoic acid
DE3562237D1 (en) Process for the preparation of 1,4-diamino-2,3-dicyanoanthraquinone
EP0206293A3 (en) Process for the preparation of 3,5-dichloro-2-pyridone

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee